See This Week’s issue of Barron’s (JY 15 p 31) for a good summary of the biotech sector. See also our article at bottom of page from Investor Uprising in 2011.We have covered many ETFs and funds over the years and have favored Fidelity Select Biotechnology Fund (FBIOX) and ETFs such as IBB and XBI. But the other funds mentioned should all be reviewed and compared:
Janus Global Life Science (JNGLX)
Franklin Biotechnology Discovery (FBDIX)
Some major issues for the sector is reiterated: pricing pressures, reimbursement and the threat of “biosimilars”.
Review this article on biotech stocks from December 2011: